Forbes

What’s The Difference Between An Application And A Web Application?

Forbes contributors publish independent expert analyses and insights. I track enterprise software application development & data management. Software builds applications. Some of those applications ...
Daily Mail

Woman suffers chemical burns after being mistakenly prescribed ERECTILE DYSFUNCTION cream called Vitaros instead of dry eye lubricant Vita-POS

A woman inadvertently put erectile dysfunction cream into her eye after a mix-up over two medications with very similar names. The patient, whose name and age are unknown, ended up with redness, ...
UroToday

The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over ...

To investigate the efficacy, tolerability, and patient's preference of alprostadil cream for topical use administered within the urethral meatus versus the standard administration route, in erectile ...
Reuters

Apricus mulls options; to sell U.S. rights to Vitaros

(Reuters) - Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug ...
Yahoo Finance

Apricus Biosciences Announces Outcome of Vitaros(TM) End-of-Review Meeting with FDA

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the outcome of ...
Benzinga.com

What's Next For Apricus Biosciences' Vitaros?

Apricus Biosciences Inc APRI receded 67.4 percent Friday and continued down Tuesday after the U.S. Food and Drug Administration issued a response letter for Vitaros. The FDA declined to approve the ...
via

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros(TM)

SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U ...
RTTNews

Apricus Biosciences Gets CRL From FDA For Vitaros

Apricus Biosciences Inc. (APRI) said that the U.S. Food and Drug Administration has issued a complete response letter or "CRL" for the New Drug Application ("NDA") of Vitaros or alprostadil, DDAIP.HCl ...
FierceBiotech

Apricus craters as FDA rejects erectile dysfunction cream again

Apricus' stock fell 73% in after-hours trading. The FDA has issued a complete response letter for Apricus’ topical erectile dysfunction (ED) drug Vitaros for the second time, sparking a massive ...
streetinsider

Apricus Biosciences (APRI) Receives CRL from FDA for Vitaros

Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S ... This is a premium only article. To ...
BioSpace

Apricus Biosciences Announces FDA Acknowledgement Of Vitaros Class 2 NDA Resubmission

SAN DIEGO, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U ...